CALGARY, Alberta, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Canadian Premium Sand Inc. (“CPS” or the “Company”) (TSXV: CPS) announces that Rodrigo Sousa has resigned from the Company’s Board of Directors effective January 29th. Mr. Sousa has been a director of the Company since 2018. The Company would like to thank Mr. Sousa for his guidance, wisdom and dedication during his tenure with CPS. About Canadian Premium Sand Inc. The Company is developing its Wanipigow silica sand resource in Manitoba to supply fracture ...

FORT COLLINS, Colo., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Woodward, Inc. (NASDAQ:WWD) today announced that its Board of Directors declared a cash dividend of $0.32 per share, an increase of 14 percent from the prior quarter’s dividend of $0.28 per share. The dividend will be payable on March 5, 2026, for stockholders of record as of February 19, 2026. About Woodward, Inc. Woodward is the global leader in the design, manufacture, and service of energy conversion and control solutions for the aerospace and indu ...

SINGAPORE, Feb. 02, 2026 (GLOBE NEWSWIRE) -- SD Government, (SDG) the division of Gogo (NASDAQ: GOGO) providing satellite communications to global governments, has received US Air Force Air Mobility Command (AMC) T-1 certification for the Roll-on/Roll-off (RO/RO) Beyond Line of Sight (BLOS) Tactical Removeable Airborne Satellite Communications (TRASC) capability for C-130 aircraft. The T-1 certification will provide multiple satcom options, beginning with a Gogo Plane Simple Ku-band terminal, and subsequent ...

Deficiencies limited to packaging and administrationCompany believes it can rapidly resolve deficiencies and expects to resubmit as early as Q3 2026Remains well-capitalized and anticipates ending 2026 with significant cashReiterates plans to submit in Canada and EU by the end of 2026Company to host investor call on February 2, 2026, at 8:00am ET WARREN, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medic ...

TOKYO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- CTW Cayman (Nasdaq: CTW) ("CTW" or "the Company"), a leading game platform company providing global access to web-based games through its flagship HTML5 platform G123.jp, today announced the opening of its first North American office in New York City, located in the World Trade Center. The establishment of a physical presence in North America marks an important milestone in CTW’s long-term growth strategy and reflects the Company’s continued investment in expanding i ...

- The U.S. Securities and Exchange Commission (“SEC”) has declared effective the registration statement on Form S-4 (File No. 333- 290631) (as amended, the “Registration Statement”) filed by Eagle Nuclear Energy Corp. (“New Eagle”) and co-registrant Eagle Energy Metals Corp. (“Eagle”) - - Extraordinary General Meeting of Shareholders of Spring Valley Acquisition Corp. II (OTC: SVIIF) (“SVII”) to approve proposed business combination with New Eagle and Eagle (the “Proposed Business Combination”) to be held o ...

OKLAHOMA CITY and HOUSTON, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Devon Energy (“Devon”) (NYSE: DVN) and Coterra Energy (“Coterra”) (NYSE: CTRA) today announced the signing of a definitive agreement to merge in an all-stock transaction. The combination will create a leading large-cap shale operator with a high-quality asset base anchored by a premier position in the economic core of the Delaware Basin. The combined company will be named Devon Energy and will be headquartered in Houston while maintaining a signif ...

Core Insights - Eton Pharmaceuticals has licensed U.S. marketing rights for an ultra-rare disease product candidate, which is expected to be the first and only generic alternative for a treatment impacting fewer than 100 patients in the U.S. [1][2] Company Overview - Eton Pharmaceuticals focuses on developing and commercializing treatments for rare diseases, currently offering eight commercial products and five additional candidates in late-stage development [3]. Product Development and Pipeline - The newly licensed product is under FDA review and is anticipated to be approved and launched in mid-2026, contributing to Eton's goal of expanding its ultra-rare disease product portfolio [2][5]. - The company aims to enhance patient and provider experiences through its Eton Cares patient support program, leveraging past successes with existing products [2].

Financial Results - Revenues increased by 5% to $26.0 billion from $24.7 billion in Q1 fiscal 2025 [7] - Income before income taxes for Q1 was $3.7 billion, comparable to Q1 fiscal 2025 [7] - Total segment operating income decreased by 9% to $4.6 billion from $5.1 billion in Q1 fiscal 2025 [7] - Diluted EPS decreased to $1.34 from $1.40 in Q1 fiscal 2025, while adjusted EPS decreased to $1.63 from $1.76 [7] Segment Performance Entertainment - Revenue increased by 7% compared to Q1 fiscal 2025, but operating income declined by $0.6 billion to $1.1 billion, resulting in an operating margin of 9.5% [7][19] - SVOD revenue increased by 11%, with operating income rising by $189 million to $450 million, leading to an operating margin of 8.4% [7][19] - Segment advertising revenue decreased by 6% compared to Q1 fiscal 2025 [7] Sports - Q1 segment operating income was $191 million, a decrease of $56 million compared to Q1 fiscal 2025, despite a 10% growth in advertising revenue [7][24] - The temporary suspension of YouTube TV carriage adversely impacted segment operating income by approximately $110 million [7] Experiences - Achieved record quarterly revenue of $10.0 billion with segment operating income of $3.3 billion [7] - Domestic Parks & Experiences operating income grew by 8%, with attendance up by 1% and per capita spending up by 4% [7] Guidance and Outlook - For Q2 fiscal 2026, Entertainment segment operating income is expected to be comparable to Q2 fiscal 2025, with SVOD operating income projected at approximately $500 million, an increase of about $200 million compared to Q2 fiscal 2025 [8] - Fiscal Year 2026 guidance includes double-digit segment operating income growth compared to fiscal 2025, with an expected SVOD operating margin of 10% [11] - Anticipated cash provided by operations for fiscal 2026 is $19 billion, with plans to repurchase $7 billion of stock [11]

Group 1 - The company, Realkredit Danmark, announces the final amounts of mortgage covered bonds (SDRO) to be auctioned for refinancing FlexLån and FlexLife® in series 10F starting from April 1, 2026 [1] - Approximately DKK 30 million of FlexLån® with a government guarantee will be refinanced in series 10A, with the auction scheduled for February 25, 2026, at 11:45 am [2] - Interested parties can contact RD Funding for further inquiries, specifically reaching out to the Head of RD Funding, Christian Rosenstand [3]